Benzinga··Vandana SinghTeva and Sanofi Report Positive Phase 3 Results for Duvakitug IBD Treatment
Teva and Sanofi report positive Phase 3 results for duvakitug IBD treatment, with over 55% of patients meeting efficacy endpoints. Stock rises 2.85%.
SNYTEVAmonoclonal antibodyclinical trial